20 Highest Yielding Financial Growth Stocks

The financial sector is one of the biggest sectors. Roughly 2,800 stocks and funds are listed. Only 724 of them are dividend stocks.

Today, I've made a screen of the best yielding growth stocks for the mid-term. Because of the high number of results, I've decided to exclude all stocks with a market capitalization below USD 10 billion. Ten of the results have a buy or better recommendation.

CME Group (CME) has a market capitalization of $19.09 billion. The company employs 2,740 people, generates revenue of $2.914 billion and has a net income of $906.70 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $1.945 billion. The EBITDA margin is 66.74 percent (the operating margin is 58.05 percent and the net profit margin 31.11 percent).

Financial Analysis: The total debt represents 7.35 percent of the company’s assets and the total debt in relation to the equity amounts to 13.34 percent. Due to the financial situation, a return on equity of 4.17 percent was realized. Twelve trailing months earnings per share reached a value of $2.70. Last fiscal year, the company paid $2.39 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 21.23, the P/S ratio is 6.55 and the P/B ratio is finally 0.89. The dividend yield amounts to 3.14 percent and the beta ratio has a value of 1.11.






Prudential Financial (PRU) has a market capitalization of $26.73 billion. The company employs 50,104 people, generates revenue of $49.045 billion and has a net income of $3.518 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $5.407 billion. The EBITDA margin is 11.02 percent (the operating margin is 10.43 percent and the net profit margin 7.17 percent).

Financial Analysis: The total debt represents 4.32 percent of the company’s assets and the total debt in relation to the equity amounts to 72.42 percent. Due to the financial situation, a return on equity of 10.29 percent was realized. Twelve trailing months earnings per share reached a value of $2.63. Last fiscal year, the company paid $1.45 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 21.94, the P/S ratio is 0.54 and the P/B ratio is finally 0.73. The dividend yield amounts to 2.78 percent and the beta ratio has a value of 2.36.






T. Rowe Price Group (TROW) has a market capitalization of $18.89 billion. The company employs 5,372 people, generates revenue of $3.022 billion and has a net income of $883.60 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $1.445 billion. The EBITDA margin is 47.83 percent (the operating margin is 45.14 percent and the net profit margin 29.23 percent).

Financial Analysis: The total debt represents 0.00 percent of the company’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 24.17 percent was realized. Twelve trailing months earnings per share reached a value of $3.36. Last fiscal year, the company paid $1.36 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 21.78, the P/S ratio is 6.25 and the P/B ratio is finally 4.90. The dividend yield amounts to 1.86 percent and the beta ratio has a value of 1.59.






Take a closer look at the full list of the 20 best yielding Financial stocks with higest growth. The average P/E ratio amounts to 19.10 and forward P/E ratio is 18.91. The dividend yield has a value of 2.99 percent. Price to book ratio is 1.70 and price to sales ratio 4.68. The operating margin amounts to 21.60 percent and the beta ratio is 1.65. Stocks from the list have an average debt to equity ratio of 0.94.

Here is the full table with some fundamentals (TTM):


Related stock ticker symbols:
SAN, HCN, BBVA, AEG, CME, AVB, BBT, BLK, PRU, AMP, MTB, IVZ, MMC, NTRS,
BX, GGP, HST, MET, BK, TROW

Disclosure: I am long CME. I receive no compensation to write about these specific stocks, sector or theme. I don't plan to increase or decrease positions or obligations within the next 72 hours.

For the other stocks: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.